Olanzapine News
Court backs Lilly's patent on Zyprexa until 2011
Eli Lilly is celebrating a decision by a US court that backs the company's patents on the blockbuster antipsychotic Zyprexa (olanzapine).
Company Played Down Anti-Psychotic Drug's Risk, Newspaper Reports
Zyprexa, an anti-psychotic drug and the biggest-selling medicine for pharmaceutical company Eli Lilly, may increase the risk of getting diabetes, a possibility downplayed by company executives for more than a decade, the New York...
Barr Receives Tentative Approval for a Generic Version of ZYPREXA(R) Zydis(R) Tablets, 5mg, 10mg, 15mg and 20mg
The patent listed in the Orange Book for ZYPREXA Zydis expires on April 23, 2011. Barr's Abbreviated New Drug Application (ANDA) alleges that the Orange Book listed patent is invalid, unenforceable and/or would not be infringed...
Shortening the Hospital Stays of Patients with Acute Psychosis
A new study published by physicians from the Mental Health Research Institute and Monash University of Victoria, Australia, showed that all atypical antipsychotics studied were equally efficacious when used at optimal doses as...
Optimized Use of Atypical Antipsychotics Associated With Equal Efficacy and Brief Hospital Stays in Patients With Acute Psychosis
A new study published by physicians from the Mental Health Research Institute and Monash University of Victoria, Australia, showed that all atypical antipsychotics studied were equally efficacious when used at optimal doses as...